Monday, 10 June 2019

Roche's combo lymphoma treatment wins U.S. FDA approval

The U.S. Food and Drug Administration on Monday granted earlier-than-expected approval to Roche Holding AG's antibody-drug conjugate Polivy for treatment of patients with advanced lymphoma.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)